Imperial Recognized as 2025 Best & Brightest Company to Work For in West Michigan! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Tag:

Improving Study Recruitment

    Patient Recruitment and Retention

    Tactical Tips for Turning Around Low Patient Enrollment

    by Dan McDonald August 4, 2015
    written by Dan McDonald

    We’ve all heard the statistics regarding the significant negative impact that low patient enrollment can have on drug development timelines and economics.  Basically, it’s our industry’s version of telling ghost stories around a campfire. Typically, they start off scary and end downright terrifying: +90% of trials are delayed by at least one month; direct day-to-day out of pocket operating costs of more than $100K; opportunity costs of a $1M dollars per day and up… and on and on it goes.

    How many presentations at DIA, starting off with these stats, do we have to attend before we go downright crazy and do something about it?

    Thankfully, over the course of my career and a lot of trial and error, I’ve learned a few golden nuggets with regards to turning around slow-enrolling trials.

    If you’ve ever had to manage a trial with underperforming enrollment levels (chances are, you have!), you know firsthand the headaches this can cause. Teams often feel overwhelmed and helpless.  Thankfully, over the course of my career and a lot of trial and error, I’ve learned a few golden nuggets with regards to turning around slow-enrolling trials. Fortunately, in general, clinical trial sponsors are much more proactive when it comes to planning their study enrollment strategies and tactics. In fact, the number of enrollment rescue projects we support continues to drop annually, being increasingly replaced with proactive, well-planned enrollment enhancement programs.

    There are certain pieces of the puzzle that can cause low patient enrollment levels, which should be addressed out of the gate:

    • Protocol development and stakeholder input
    • Study and site feasibility analysis
    • Investigator grants, contracts and relations
    • Availability of patient recruitment expertise and support at study sites
    • Understanding patient volumes, catchment area and sources
    • Contingency planning
    • And much more

    In order to combat low enrollment, you’ll need a solid plan of attack. This plan needs to be proactive, thoughtful, and aggressive.

    For many sponsors, too often, the approach to addressing slow enrollment is to add sites and extend enrollment timelines. While that approach might ultimately be needed, there are things that can be done first to rally the troops and right the ship.

    For example, sponsors may be tempted to conduct an aggressive and expensive direct-to-patient marketing campaign. For highly prevalent, chronic conditions, such an approach just might work.  In today’s research environment, protocol complexity is increasing, and FDA burden of proof on clinical trials and drug approvals is much more stringent. Thus, finding patients for today’s study protocols often requires a different approach – one that has to leverage the expertise of the medical community to properly identify the correctly diagnosed patient and initiate a referral to study sites. A hidden benefit of this methodology is that approaching the medical community about your trial does not require an IRB approval. In a rescue situation, time is of the essence – a medical community outreach initiative can be executed quickly and begin paying dividends while you ramp up other initiatives.

    This is just one of the secrets that come from years of experience supporting sponsors facing enrollment challenges.

    What other tips have you found to be successful?

    August 4, 2015 0 comment
    0 FacebookTwitterLinkedinEmail

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    See Do Get

    August 12, 2014
  • 2

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    Clinical Trial Supply Chains: The Key to Avoiding Disruptions

    May 10, 2022

Categories

  • Ancillary Trial Supplies and Equipment (28)
  • Business Insights (124)
  • Clinical Trial Writing and Design (36)
  • Life-Science Events (50)
  • Patient Engagement (30)
  • Patient Recruitment and Retention (93)
  • Site Materials & Logistics (44)
  • Study Site Management (21)
  • Translation of Study Materials (17)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribe to our blog and get the latest updates, insights, and industry trends delivered straight to your inbox. Stay informed and never miss a post.